Dawn Attride on Muck Rack

Dawn Attride

(She/Her)
New York
As seen in: Medscape, Forbes, Yahoo News, Flipboard, Medscape Duestch, Medscape France, Medscape Noticias Médicas, Medscape PT, Science Magazine, Yahoo, Inverse and
Covers:  Health, biology, environment, science

Get in touch with Dawn

Contact Dawn, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Dawn Attride’s Biography

Read Full Bio →

Science journalist covering health, biology and environmental issues | NYU SHERP 42 | B.A Microbiology, Trinity College Dublin

Dawn Attride’s Journalist Portfolio

Can Weed Make Recreational Running Easier? These Runners and Scientists Are Racing To Find Out

Can Weed Make Recreational Running Easier? These Runners and Scientists Are Racing To Find Out

A growing number of recreational runners and marathoners have turned to weed to enhance their running experie…

View article →
Troubled Waters: Uranium Mine May Pose Threat to Grand Canyon Drinking Water

Troubled Waters: Uranium Mine May Pose Threat to Grand Canyon Drinking Water

View article →
Can Scientists Stem Antimicrobial Resistance With Designer Microbiomes?

Can Scientists Stem Antimicrobial Resistance With Designer Microbiomes?

Inside a new approach to combating a global health crisis.

View article →
Did Flint water crisis set kids back in school? Paper saying so is 'severely flawed,' say critics

Did Flint water crisis set kids back in school? Paper saying so is 'severely flawed,' say critics

View article →
Battle of the bogs: Farmers and EU face off over Ireland's largest carbon store

Battle of the bogs: Farmers and EU face off over Ireland's largest carbon store

Farmers in Ireland have long burned carbon-rich peat to heat rural homes, but the practice has come under fir…

View article →
The "Wild West" of childhood psychiatric prescriptions - Scienceline

The "Wild West" of childhood psychiatric prescriptions - Scienceline

Off-label prescribing is common in childhood psychiatrics, resulting in risky results for kids.

View article →

Articles

Evidence for tVNS Stronger for Reducing Anxiety vs Enhancing Cognition

|
By Dawn Attride
| Medscape Verified
SAN FRANCISCO — Transcutaneous vagus nerve stimulation (tVNS) has emerged as a promising tool for everything from anxiety to cognitive enhancement, but two new meta-analyses suggest the evidence is stronger for easing anxiety than boosting cognition. In the first analysis, tVNS was associated with significantly reduced anxiety severity, although the overall magnitude of improvement was modest.
Open in Who Shared Issue with article?

Lumateperone Linked to Lower Risk for Schizophrenia Relapse

|
By Dawn Attride
| Medscape Verified
SAN FRANCISCO — Treatment with lumateperone was associated with a 63% lower risk for relapse compared with placebo in patients with schizophrenia, new trial data showed. Findings from the phase 3, double-blind, randomized trial revealed that 84% of lumateperone patients were relapse-free at 6 months, with no clinically meaningful changes in prolactin, cardiometabolic parameters, or weight.
Open in Who Shared View Duplicates (2) Issue with article?

Tool Predicts Risk for Difficult-To-Treat Depression Before Multiple Treatment Failures

|
By Dawn Attride
| Medscape Verified
SAN FRANCISCO — A novel self-report questionnaire may help identify patients who are at risk for difficult-to-treat depression before they meet the criteria for treatment-resistant depression (TRD). Building on earlier research, investigators assessed whether the Difficult-to-Treat Depression Questionnaire (DTDQ) could predict outcomes in patients with major depressive disorder (MDD) who had not responded to multiple antidepressant treatments.
Open in Who Shared Issue with article?
See all 143 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified